Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/19/2014 - 06/19/2017

This course is closed. Please look for other available products in CPNP University.

Target Audience

This application-level activity is designed for pharmacists and other healthcare professionals with minimal experience in psychiatry who have an interest in learning more about the treatment of social anxiety disorder.

Session Summary

This course is designed to provide participants with minimal experience a review of evidenced-based first line strategies for the treatment of obsessive compulsive disorder. The goal is that participants will be able to formulate an effective and safe drug therapy plan that can be implemented in a patient with uncomplicated obsessive compulsive disorder. The course will require 1.5 hours for completion and will consist of review of a recommended reading and completion of a patient case study. At the conclusion of the course, an evidence-based key will be provided for the case.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Complete the pre-test before starting the activity. (login first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

The course consists of review of a recommended reading(s) and completion of a patient case study. At the conclusion of the course, an evidence-based key will be provided for the case. If the recommended reading is a CPNP product, it is provided. If not, it is the responsibility of the participant to locate the reading.

Faculty Information and Disclosures

Charles F. Caley, PharmD, BCPP

View biographical information and disclosures

Learning Objectives

  1. Recognize the symptoms, clinical features, and treatment goals for Obsessive-Compulsive Disorder.
  2. Recommend and optimize appropriate pharmacologic and non-pharmacologic therapy for patients with Obsessive-Compulsive Disorder.
  3. Develop an appropriate treatment and monitoring plan for a patient with Obsessive-Compulsive Disorder on the basis of individual patient characteristics.
  4. Educate patients and caregivers on taking medications for Obsessive-Compulsive Disorder.

Continuing Education Credit and Disclosures

Activity Dates: 06/19/2014 - 06/19/2017
ACPE Contact Hours: 1.5
ACPE Number: 0284-0000-14-067-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.5 contact hours (0.15 CEUs) of application-based continuing education credit. The ACPE universal program number assigned to this course is 0284-0000-14-067-H01-P (1.5 contact hours).

This educational activity does not contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA).

Grant Support

This activity is sponsored by the College of Psychiatric and Neurologic Pharmacists (CPNP) and supported through educational grants from Eli Lilly, Merck, Otsuka America Pharmaceutical Inc., and Sunovion Pharmaceuticals Inc.